ReviewImmunity, inflammation and disease2026
Chandipura Virus: An Emerging Neurological Threat Transmitted by Sandflies in India.
Review in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chandipura virus encephalitis: an emerging pediatric neurotropic threat in india-virology, epidemiology, pathogenesis, and public health challenges.Journal of neurovirology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChandipura virus (CHPV), a neurotropic, negative-sense RNA virus belonging to the genus Vesiculovirus (family Rhabdoviridae), has emerged as a significant cause of acute encephalitis syndrome (AES) in India, predominantly affecting children. Since the major outbreaks in 2003-2004 and the recent resurgence in 2024, CHPV has re-emerged as a high-fatality, climate-sensitive arboviral threat transmitted primarily by phlebotomine sandflies. The absence of specific antivirals or licensed vaccines underscores the need for comprehensive understanding and preparedness.
methodsThis narrative review synthesizes available literature on CHPV epidemiology, outbreak history, molecular virology, transmission ecology, neuropathogenesis, host immune responses, diagnostic modalities, therapeutic candidates, and preventive strategies. Data from published outbreak reports, genomic analyses, experimental studies, and public health updates were critically examined to provide an integrated One Health perspective.
resultsCHPV outbreaks have been characterized by rapid disease progression, high case-fatality rates (often 30%-70%), and marked pediatric predominance. Molecular studies reveal a conserved vesiculovirus genomic organization (3'-N-P-M-G-L-5'), with emerging phylogenomic evidence indicating geographic clustering but limited global genomic representation. Neurotropism is mediated by rapid viral replication in the central nervous system, triggering microglial activation, oxidative stress, cytokine dysregulation, complement interactions, and Fas-mediated neuronal apoptosis. Diagnosis relies primarily on RT-PCR during the early viremic phase and IgM ELISA in later stages, though rapid field-deployable diagnostics remain unavailable. Experimental antiviral strategies, including ribavirin, favipiravir, lycorine, RNA interference, and immunomodulatory approaches, demonstrate preclinical promise but lack human clinical validation. Vector control and environmental management remain the cornerstone of prevention.
conclusionChandipura virus represents a re-emerging neuroinvasive arbovirus with significant public health implications in India. Strengthening AES surveillance, integrating genomic monitoring, developing rapid diagnostics, advancing antiviral and vaccine research, and implementing climate-informed vector control strategies are critical priorities. A coordinated One Health framework is essential to mitigate future outbreaks and reduce pediatric mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.